Global Conference on Nanomedicine, Nanobiology, Nanotechnology & Pharmacology
  • Follow

Accepted Abstracts

Development and Evaluation of Nanocarriers of an Anticancer Drug for the treatment of Breast Cancer

Ahmed Mohammed Abdalla *, Usha G.K, B Prakash Rao, Ajay Kumar Chouhan
Rajiv Gandhi University of Health Sciences, India

Citation: Abdalla AM, USha GK< Rao BP, Chouhan AK (2019) Development and Evaluation of Nanocarriers of an Anticancer Drug for the treatment of Breast Cancer. SciTech Nanosciences-Pharma 2019. Tokyo: Japan

Received: July 30, 2019         Accepted: August 01, 2019         Published: August 01, 2019

Abstract

The current goal of the research work was to develop and evaluate Docetaxel nanoparticles as potential carrier system to facilitate targeted delivery to tumour cells. Central composite design was used to optimize Docetaxel loaded Pluronic F68 nanoparticles. Drug loaded Pluronic F68 nanoparticles were prepared by anti solvent precipitation method and was characterized for FTIR, DSC, Entrapment efficiency, Drug Content, % Yield, SEM and in vitro release studies. Docetaxel with Pluronic F68 showed no interaction based on the results from FTIR and DSC. Polymer concentration affected the entrapment efficiency, drug content and percentage yield. The more the polymer concentration the more was the yield, the more was the entrapment efficiency. The in-vitro release study was performed and at 12th hour the release ranged between 81.28-91.71 %. The average particle size was found to be 62.51 nm.